Russell Skibsted - Net Worth and Insider Trading
Russell Skibsted Net Worth
The estimated net worth of Russell Skibsted is at least $1,139 dollars as of 2024-11-28. Russell Skibsted is the CFO of Lineage Cell Therapeutics Inc and owns about 2,000 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $1,138. Russell Skibsted is also the CFO of Aeolus Pharmaceuticals Inc and owns about 17,027 shares of Aeolus Pharmaceuticals Inc (AOLS) stock worth over $2. Details can be seen in Russell Skibsted's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Russell Skibsted has not made any transactions after 2017-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Russell Skibsted
Russell Skibsted Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Russell Skibsted owns 7 companies in total, including Rockwell Medical Inc (RMTI) , AgeX Therapeutics Inc (AGE) , and Lineage Cell Therapeutics Inc (LCTX) among others .
Click here to see the complete history of Russell Skibsted’s form 4 insider trades.
Insider Ownership Summary of Russell Skibsted
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RMTI | Rockwell Medical Inc | 2022-09-09 | See Remarks |
| AGE | AgeX Therapeutics Inc | 2018-11-27 | Chief Financial Officer |
| LCTX | Lineage Cell Therapeutics Inc | 2017-08-23 | Chief Financial Officer |
 | | 2015-12-30 | Chief Financial Officer |
| | 2014-06-30 | Former Executive Vice Pres. & other: Former Chief Financial Officer |
| | 2013-03-08 | Chief Financial Officer |
| | 2023-03-26 | Chief Financial Officer & SVP |
Russell Skibsted Latest Holdings Summary
Russell Skibsted currently owns a total of 2 stocks. Among these stocks, Russell Skibsted owns 2,000 shares of Lineage Cell Therapeutics Inc (LCTX) as of August 23, 2017, with a value of $1,138 and a weighting of 99.85%. Russell Skibsted also owns 17,027 shares of Aeolus Pharmaceuticals Inc (AOLS) as of May 23, 2012, with a value of $2 and a weighting of 0.15%.
Latest Holdings of Russell Skibsted
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2017-08-23 | 2,000 | 0.57 | 1,138 |
| AOLS | Aeolus Pharmaceuticals Inc | 2012-05-23 | 17,027 | 0.00 | 2 |
Holding Weightings of Russell Skibsted
Russell Skibsted Form 4 Trading Tracker
According to the SEC Form 4 filings, Russell Skibsted has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 2,000 shares on August 23, 2017, which cost Russell Skibsted around $5,280.
According to the SEC Form 4 filings, Russell Skibsted has made a total of 0 transactions in Aeolus Pharmaceuticals Inc (AOLS) over the past 5 years. The most-recent trade in Aeolus Pharmaceuticals Inc is the acquisition of 7,027 shares on May 23, 2012, which cost Russell Skibsted around $1,686.
Insider Trading History of Russell Skibsted
- 1
Russell Skibsted Trading Performance
GuruFocus tracks the stock performance after each of Russell Skibsted's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Russell Skibsted is 8.45%. GuruFocus also compares Russell Skibsted's trading performance to market benchmark return within the same time period. The performance of stocks bought by Russell Skibsted within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Russell Skibsted's insider trading performs compared to the benchmark.
Performance of Russell Skibsted
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.2 | | | | | |
| Relative Return to S&P 500(%) | 3.59 | | | | | |
Russell Skibsted Ownership Network
Russell Skibsted Owned Company Details
What does Rockwell Medical Inc do?
Who are the key executives at Rockwell Medical Inc?
Russell Skibsted is the See Remarks of Rockwell Medical Inc. Other key executives at Rockwell Medical Inc include other: See Footnote 1 Mark H Ravich , director & President and CEO Mark Strobeck , and SVP & FINANCE Jesse Neri .
Rockwell Medical Inc (RMTI) Insider Trades Summary
Over the past 18 months, Russell Skibsted made no insider transaction in Rockwell Medical Inc (RMTI). Other recent insider transactions involving Rockwell Medical Inc (RMTI) include a net sale of 29,991 shares made by Mark H Ravich , a net sale of 2,163 shares made by Mark Strobeck , and a net sale of 1,001 shares made by .
In summary, during the past 3 months, insiders sold 33,155 shares of Rockwell Medical Inc (RMTI) in total and bought 0 shares, with a net sale of 33,155 shares. During the past 18 months, 33,155 shares of Rockwell Medical Inc (RMTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 33,155 shares.
Rockwell Medical Inc (RMTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rockwell Medical Inc Insider Transactions
Russell Skibsted Mailing Address
Above is the net worth, insider trading, and ownership report for Russell Skibsted. You might contact Russell Skibsted via mailing address: 15 Tranquility Place, Ladera Ranch Ca 92694.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
